WO2018066341A1 - Oral composition and method for suppressing discoloration of formulation and liquid separation thereof - Google Patents
Oral composition and method for suppressing discoloration of formulation and liquid separation thereof Download PDFInfo
- Publication number
- WO2018066341A1 WO2018066341A1 PCT/JP2017/033453 JP2017033453W WO2018066341A1 WO 2018066341 A1 WO2018066341 A1 WO 2018066341A1 JP 2017033453 W JP2017033453 W JP 2017033453W WO 2018066341 A1 WO2018066341 A1 WO 2018066341A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- component
- mass
- liquid separation
- oral cavity
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 239000007788 liquid Substances 0.000 title claims abstract description 30
- 238000002845 discoloration Methods 0.000 title claims abstract description 29
- 238000000926 separation method Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 7
- 238000009472 formulation Methods 0.000 title abstract description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims abstract description 50
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 25
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229930007845 β-thujaplicin Natural products 0.000 claims abstract description 25
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 17
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 16
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 16
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 16
- 239000010452 phosphate Substances 0.000 claims abstract description 15
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 7
- -1 Fluorine ions Chemical class 0.000 claims description 37
- 210000000214 mouth Anatomy 0.000 claims description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 229910052731 fluorine Inorganic materials 0.000 claims description 14
- 239000011737 fluorine Substances 0.000 claims description 14
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 12
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 7
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 7
- 239000011775 sodium fluoride Substances 0.000 claims description 6
- 235000013024 sodium fluoride Nutrition 0.000 claims description 6
- 239000000551 dentifrice Substances 0.000 claims description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 claims description 2
- NGPNWUWGVIIIDG-LEJBHHMKSA-L magnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] phosphate Chemical class [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP([O-])([O-])=O NGPNWUWGVIIIDG-LEJBHHMKSA-L 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 abstract description 7
- 230000000694 effects Effects 0.000 description 23
- 235000019606 astringent taste Nutrition 0.000 description 19
- 235000019658 bitter taste Nutrition 0.000 description 19
- 235000002639 sodium chloride Nutrition 0.000 description 15
- 235000021317 phosphate Nutrition 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 208000028169 periodontal disease Diseases 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- 229940034610 toothpaste Drugs 0.000 description 6
- 239000003082 abrasive agent Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- 239000010902 straw Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000004137 magnesium phosphate Substances 0.000 description 2
- 229960002261 magnesium phosphate Drugs 0.000 description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 2
- 235000010994 magnesium phosphates Nutrition 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- SLQVHWZLWVVHBD-UHFFFAOYSA-N 2-(2-oxotridecylamino)ethanesulfonic acid Chemical compound CCCCCCCCCCCC(=O)CNCCS(O)(=O)=O SLQVHWZLWVVHBD-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- SVIJYLPSHPPVQF-UHFFFAOYSA-N 2-[2,2-diaminoethyl(dodecyl)amino]acetic acid Chemical compound CCCCCCCCCCCCN(CC(N)N)CC(O)=O SVIJYLPSHPPVQF-UHFFFAOYSA-N 0.000 description 1
- GMGBBMQOXFAWRS-UHFFFAOYSA-N 2-[2,2-diaminoethyl(tetradecyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCN(CC(N)N)CC(O)=O GMGBBMQOXFAWRS-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241001117244 Chamaecyparis formosensis Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000862969 Stella Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000218638 Thuja plicata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- XYSJYAQKIAGPFT-UHFFFAOYSA-N heptatriacontan-19-ylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCC([NH3+])CCCCCCCCCCCCCCCCCC XYSJYAQKIAGPFT-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229910052806 inorganic carbonate Inorganic materials 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to an oral composition containing hinokitiol and having excellent appearance stability over time, and a method for inhibiting formulation discoloration and liquid separation in the oral composition.
- Hinokitiol is often used in oral compositions such as dentifrices as a natural product-derived ingredient that has antibacterial and bactericidal effects on periodontal disease-causing bacteria in the oral cavity, but it causes discoloration of the preparation and phase separation.
- Patent Document 1 Japanese Patent No. 5600872 proposes that discoloration and phase-liquid separation of a hinokitiol-containing toothpaste composition can be suppressed by a specific combination of edetic acid, ethanol and water.
- Patent Document 2 Japanese Patent Laid-Open No.
- ascorbic acid phosphate ester such as magnesium ascorbate or a salt thereof is a medicinal component for oral compositions, but is also known as a component with problems such as discoloration of preparations.
- JP-A-11-286422 and JP-A-2000-256152 have proposed oral compositions containing acid esters in which discoloration is suppressed.
- the ascorbic acid derivative itself has a discoloration suppressing effect.
- the present invention has been made in view of the above circumstances, and an object of the present invention is to provide an oral composition containing hinokitiol and having excellent appearance stability over time.
- the present inventor has further added fluoride ions to the oral composition containing both hinokitiol and ascorbic acid phosphate ester or salts thereof, both of which have coloring problems. It was found that, when blended in a specific amount and proportion, coloring was suppressed, and the appearance of liquid separation by the combined use system was prevented, excellent appearance stability was given over time, and a good feeling of use could be imparted. . That is, in the present invention, it contains (A) hinokitiol, (B) ascorbic acid phosphate ester or salt thereof, and (C) fluorine ion, and the content of (C) component is 0.0001 to 0.27% by mass.
- composition for oral cavity in which ((A) + (B)) / (C) indicating the blending ratio of the components (A) and (B) to the component (C) is 0.5 to 11,000 as a mass ratio
- the product was found to have excellent appearance stability over time and good usability (astringency, bitterness, tastelessness) and led to the present invention.
- the present inventor has combined the component (C) with the combination system of the components (A) and (B), and the content of the component (C) and (( The mass ratio of A) + (B)) / (C) was within a specific range, and the discoloration and liquid separation of the preparation were suppressed over time, and the taste was also improved.
- the unique and exceptional problem that the problem of discoloration that cannot be achieved simply by blending the (A) component and the (C) component can be solved by using a three-component system including the (B) component having the same discoloration problem. It was possible to give a good effect.
- the preparation is discolored without causing significant discoloration even after storage at 50 ° C. for 1 month.
- An excellent discoloration suppressing effect that suppresses and an excellent liquid separation suppressing effect that sufficiently suppresses without causing significant liquid separation of 1 cm or more when extruded from a container accommodated even after storage at 50 ° C. for 1 month, and ( Astringent taste, bitter taste, and off-flavor produced by the combined use of components A) and (B) can be suppressed to give a good feeling of use.
- the present invention [I] (A) Hinokitiol, (B) Ascorbic acid phosphate or a salt thereof, (C) Fluorine ions are contained, the content of component (C) is 0.0001 to 0.27% by mass, and the blending ratio of components (A) and (B) to component (C) is shown (( A composition for oral cavity, wherein A) + (B)) / (C) is a mass ratio of 0.5 to 11,000, and [II] (A) hinokitiol and (B) ascorbic acid phosphate An oral composition containing an ester or a salt thereof, (C) 0.0001 to 0.27% by mass of fluorine ions, and the blending ratio of the components (A) and (B) to the component (C) (( A preparation comprising the components (A) and (B) in the composition for oral cavity, wherein A) + (B)) / (C) is blended in a mass ratio of 0.5 to 11,000.
- the present invention it is possible to provide a composition for oral cavity containing hinokitiol and ascorbic acid phosphate or a salt thereof, which has excellent appearance stability over time and good usability (astringency, bitterness, tastelessness). .
- the oral composition of the present invention has a high preventive or ameliorating effect on periodontal diseases, and is useful for preventing or improving periodontal diseases.
- composition for oral cavity of this invention contains (A) hinokitiol, (B) ascorbic acid phosphate ester or its salt, and (C) fluorine ion.
- Hinokitiol is a unique component contained in Aomori Hiba, a natural tree, and is a crystalline acidic compound. Other tree species containing hinokitiol include Taiwan cypress, North American Western red cedar and the like. Hinokitiol has strong antibacterial activity and a broad antibacterial spectrum, is one of the few natural fungicides, and has an effect of preventing or improving periodontal diseases.
- hinokitiol includes a chemically synthesized product, and in the present invention, a natural product or a synthetic product may be used. Such hinokitiol is widely used in foods, cosmetics, pharmaceuticals, agricultural supplies, building materials, baits, etc., and in the present invention, commercially available products used for these can be used. it can.
- the amount of hinokitiol is preferably 0.005 to 0.5% (mass%, the same applies hereinafter) of the whole composition, more preferably 0.01 to 0.2%. As the blending amount increases, the effect of preventing or improving periodontal disease increases, but when it is 0.5% or less, the feeling of use (astringency, bitterness, and taste) can be maintained sufficiently and satisfactorily.
- Ascorbic acid phosphates include those in which one or more of the hydroxyl groups at positions 2, 3, 5, and 6 of ascorbic acid are converted to phosphates, for example, ascorbic acid-2- Examples thereof include phosphoric acid ester, ascorbic acid-3-phosphate ester, ascorbic acid-6-phosphate ester and the like. Examples of these salts include sodium salt, potassium salt, calcium salt, magnesium salt and the like. 1 type (s) or 2 or more types chosen from these can be used as (B) ascorbic acid phosphate ester or its salt.
- a derivative in which the hydroxyl group at the 2-position or 3-position of ascorbic acid is converted to a phosphate ester is preferable, and a magnesium salt or sodium salt of ascorbyl 2-phosphate ester is more preferable.
- a magnesium salt is particularly preferred.
- the blending amount of ascorbic acid phosphate or a salt thereof is preferably 0.1 to 5%, more preferably 0.2 to 4% of the entire composition. When it is 0.1% or more, the effect of suppressing discoloration and liquid separation of the present invention is particularly excellent. When it is 5% or less, the effect of suppressing discoloration and liquid separation is particularly good.
- Fluorine ions can be blended as a fluorine-containing compound that supplies fluorine ions.
- the fluorine-containing compound include sodium fluoride, sodium monofluorophosphate, tin fluoride and the like, and one or more selected from these can be used.
- sodium fluoride and sodium monofluorophosphate are preferable from the viewpoint of imparting the effect of the present invention, and sodium monofluorophosphate is more preferable.
- the blending amount of (C) fluorine ions is 0.0001 to 0.27%, preferably 0.001 to 0.19% of the entire composition.
- the fluorine-containing compound is blended within the range of the blending amount of the fluorine ions, and the blending amount can be obtained by conversion from the fluorine ion amount.
- the preferable blending amount is 0.001 to 2%, particularly 0.01 to 1.4% of the whole composition.
- the preferred blending amount is 0.0003 to 0.58%, particularly 0.001 to 0.41% of the entire composition.
- ((A) + (B)) / (C) indicating the ratio of the total blending amount of the components (A) and (B) to the blending amount of the fluorine ion of the component (C) is 0 as a mass ratio.
- the discoloration-suppressing effect and liquid separation-suppressing effect of the preparation are excellent, and the feeling of use (astringency, bitterness, tastelessness) is excellent.
- ((A) + (B)) / (C) is less than 0.5, the effect of suppressing liquid separation is reduced, and the feeling of use (astringency, bitterness, and taste) is inferior.
- it exceeds 11,000 the discoloration suppressing effect and the liquid separation suppressing effect of the preparation are lowered, and the feeling of use (astringency, bitterness, tastelessness) is inferior.
- the oral composition of the present invention is not limited in its shape and dosage form, but in particular, it is prepared in a semi-solid form such as paste or gel and used as a dentifrice such as toothpaste or gel toothpaste, especially toothpaste. Can be suitably prepared.
- composition for oral cavity of the present invention in addition to the above-mentioned components, known oral additive components (pharmacologically acceptable carriers) according to the dosage form and the like within a range not impairing the effects of the present invention Can be blended.
- an additive component in dentifrices, for example, abrasives, binders, surfactants, wetting agents, coloring agents, preservatives, sweeteners, fragrances, pH adjusters, (A), (B), (C) Examples include active ingredients other than the ingredients.
- the specific example of an additional component is shown below, the component which can be mix
- silica-based abrasives such as silica gel, precipitated silica, anhydrous silicic acid, aluminosilicate, zirconosilicate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tribasic magnesium phosphate, zeolite, Examples thereof include zirconium silicate, hydroxyapatite, and a synthetic resin abrasive.
- the blending amount of the abrasive is usually 2 to 40%, particularly 10 to 25% of the whole composition.
- a silica-based abrasive is preferred as the abrasive, particularly in terms of suppressing discoloration of the preparation, and a silica-based abrasive is particularly preferred as the main abrasive.
- abrasives other than silica-based abrasives may not be blended, but when blended, the blending amount is 10% or less, particularly 1 to 8% is preferable, and not blended (0%) is more preferable.
- gums such as sodium polyacrylate, xanthan gum, guar gum, carboxymethylcellulose sodium, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxymethylethylcellulose, methylcellulose, cellulose derivatives such as cationized cellulose, carrageenan, Examples include sodium alginate, montmorillonite, and gelatin. Especially, the 1 type or 2 types chosen from a xanthan gum and a sodium polyacrylate from the point of the expression of the liquid-separation inhibitory effect is preferable.
- the amount of the binder is usually 0.1 to 10%, particularly 0.5 to 5% of the whole composition.
- an anionic surfactant such as sodium lauryl sulfate and sodium myristyl sulfate, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate, sodium ⁇ -olefin sulfonate, sodium lauroyl sarcosine , Acylamino acid salts such as lauroylmethyltaurine, ⁇ -sulfo fatty acid alkyl ester / sodium, alkyl phosphate ester cationic surfactant: distearylmethylammonium chloride, stearyldimethylbenzylammonium chloride
- Nonionic surfactant sorbitan fatty acid
- wetting agent examples include propylene glycol, pentylene glycol, hexylene glycol, octylene glycol, polyethylene glycol having an average molecular weight of 200 to 6,000 (average molecular weight described in Quasi-drug Raw Material Standard 2006), ethylene glycol, 1,3 -Polyhydric alcohols such as butylene glycol and glycerin, sugar alcohols such as sorbitol, xylitol, erythritol, and reduced starch saccharified product.
- the amount of the wetting agent is usually 5 to 50%, particularly 20 to 45% of the whole composition.
- sweetening agent examples include saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perilartin and the like.
- fragrance those known as oral fragrances can be used.
- menthol anethole, carvone, eugenol, limonene, n-decyl alcohol, citronellol, ⁇ -terpineol, citronellyl acetate, cineol, linalool, ethyl linalool, vanillin, thymol, spearmint oil, peppermint oil, lemon oil, orange oil
- Examples include sage oil, rosemary oil, cinnamon oil, pimento oil, cinnamon oil, perilla oil, winter green oil, clove oil, eucalyptus oil and the like.
- the blending amount of the fragrance is preferably 0.000001 to 2% of the entire composition.
- the pH adjuster examples include organic acids such as citric acid, lactic acid, malic acid and salts thereof, and inorganic compounds such as hydrochloric acid, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, and the like. .
- the pH (25 ° C.) of the composition is preferably 8 or more, particularly 8.1 to 9.3, particularly from the viewpoint of the stability of the component (B).
- water is used as a solvent.
- the lower monohydric alcohol such as ethanol may be added in an amount of about 1 to 10%, but may not be added (0%).
- the amount of water is not particularly limited, and can usually be in the range of 5 to 95% by mass.
- the oral composition of the present invention when it is a dentifrice, it can be preferably 5 to 70%, more preferably 10 to 60%.
- compositions (toothpaste) having the compositions shown in Tables 1 and 2 were prepared by a conventional method and evaluated by the following methods. The results are shown in the table.
- ((A) + (B)) / (C) in the table is a mass ratio indicating the ratio of the total blending amount of the (A) and (B) components to the blending amount of the fluorine ions of the (C) component. Yes (the same applies below).
- the pH (25 ° C.) of each composition was adjusted within the range of 8.1 to 9.3 (the same applies hereinafter).
- the compositions for oral cavity of the Examples all have the effects of the (A) and (B) components effectively acting to sufficiently exhibit the medicinal effects, and have a high periodontal disease prevention or improvement effect.
- Discoloration evaluation method Three oral compositions filled in an 8 mm diameter laminated tube were stored at 50 ° C. for 1 month or ⁇ 5 ° C. for 1 month, and then the oral composition on a straw half paper. The object was extruded 10 cm, and five expert panelists of the test subjects observed changes in color tone of the product stored at 50 ° C. compared to the product stored at ⁇ 5 ° C., and sensory evaluation was performed according to the following four grades. The average value of the score results of five people for three was obtained and judged according to the following evaluation criteria. ⁇ The above was deemed acceptable because discoloration of the preparation was suppressed over time.
- Criterion criteria for liquid separation 4 points No liquid separation is observed 3 points: When extruded, there is almost no liquid separation at the mouth, and there is no problem in use 2 points: When pushed, liquid separation is 1 to 3 cm at the mouth Permitted 1 point: When extruded, liquid separation exceeds 3 cm at the mouth. Evaluation criteria ⁇ : 3.5 or more and 4.0 or less ⁇ : 3.0 or more and less than 3.5 ⁇ : 2 .0 point or more and less than 3.0 point ⁇ : less than 2.0 point
- composition for oral cavity of Reference Example did not cause liquid separation over time, and did not develop astringency, bitterness or off-taste, and had a good feeling of use.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Provided is an oral composition comprising (A) hinokitiol, (B) ascorbic acid phosphate or a salt thereof, and (C) fluorine ion, wherein the content of component (C) is 0.0001 to 0.27% by mass, and ((A)+(B))/(C) which represents the mixing ratio of components (A) and (B) with respect to component (C) is 0.5 to 11000 as a mass ratio. Also provided is a method for suppressing discoloration of formulations and liquid separation in an oral composition that comprises components (A) and (B) due to components (A) and (B), wherein component (C) is compounded in the specified range into the oral composition, and components (A), (B), and (C) are compounded within the specified range in the ratio, ((A)+(B))/(C).
Description
本発明は、ヒノキチオールを含有し、外観安定性が経時でも優れる口腔用組成物及び前記口腔用組成物における製剤変色及び液分離の抑制方法に関する。
The present invention relates to an oral composition containing hinokitiol and having excellent appearance stability over time, and a method for inhibiting formulation discoloration and liquid separation in the oral composition.
ヒノキチオールは、口腔内の歯周病原因菌への抗菌・殺菌作用を有する天然物由来成分として、歯磨剤等の口腔用組成物にしばしば用いられているが、製剤の変色や相液分離を引き起こす課題が知られている。特許文献1(特許第5600872号公報)では、特定のエデト酸、エタノール及び水の組み合わせによってヒノキチオール含有練歯磨組成物の変色及び相液分離を抑制できることが提案されている。特許文献2(特開平11-130648号公報)では、水溶性無機炭酸塩とヒノキチオールを含む弱アルカリ性の口腔用組成物に水溶性亜硫酸塩類を配合することによって、着色及び残存率低下を抑制できることが提案されている。特許文献3(特開2002-3354号公報)では、ヒノキチオールを含有する口腔用組成物をフェノール樹脂及びブチラール樹脂から選ばれる樹脂でコーティングしたアルミニウムチューブに充填することによってヒノキチオールの残存率低下が抑制できることが提案されている。
Hinokitiol is often used in oral compositions such as dentifrices as a natural product-derived ingredient that has antibacterial and bactericidal effects on periodontal disease-causing bacteria in the oral cavity, but it causes discoloration of the preparation and phase separation. The problem is known. Patent Document 1 (Japanese Patent No. 5600872) proposes that discoloration and phase-liquid separation of a hinokitiol-containing toothpaste composition can be suppressed by a specific combination of edetic acid, ethanol and water. In Patent Document 2 (Japanese Patent Laid-Open No. 11-130648), coloring and remaining rate reduction can be suppressed by blending water-soluble sulfites with a weakly alkaline oral composition containing a water-soluble inorganic carbonate and hinokitiol. Proposed. In Patent Document 3 (Japanese Patent Application Laid-Open No. 2002-3354), a decrease in the residual rate of hinokitiol can be suppressed by filling an oral tube composition containing hinokitiol into an aluminum tube coated with a resin selected from a phenol resin and a butyral resin. Has been proposed.
一方、アスコルビン酸リン酸エステルマグネシウム等のアスコルビン酸リン酸エステル又はその塩は、口腔用組成物用の薬効成分であるが、製剤変色などの課題がある成分としても知られており、これまでアスコルビン酸エステルを含有する変色が抑制された口腔用組成物が特許文献4、5(特開平11-286422号公報、特開2000-256152号公報)に提案されている。しかし、アスコルビン酸誘導体自体に変色抑制効果があることは知られていない。
On the other hand, ascorbic acid phosphate ester such as magnesium ascorbate or a salt thereof is a medicinal component for oral compositions, but is also known as a component with problems such as discoloration of preparations. JP-A-11-286422 and JP-A-2000-256152 have proposed oral compositions containing acid esters in which discoloration is suppressed. However, it is not known that the ascorbic acid derivative itself has a discoloration suppressing effect.
本発明は、上記事情に鑑みなされたもので、ヒノキチオールを含有し、外観安定性が経時でも優れた口腔用組成物を提供することを目的とする。
The present invention has been made in view of the above circumstances, and an object of the present invention is to provide an oral composition containing hinokitiol and having excellent appearance stability over time.
本発明者は、上記目的を達成するため鋭意検討を行った結果、共に着色課題を有するヒノキチオールとアスコルビン酸リン酸エステル又はその塩とを併用して配合した口腔用組成物に、更にフッ素イオンを特定の量及び割合で配合すると、着色が抑制され、しかも併用系による液分離の発現を防止して、経時でも優れた外観安定性を与え、また、味の良い使用感を付与できることを知見した。即ち、本発明では、(A)ヒノキチオール、(B)アスコルビン酸リン酸エステル又はその塩、及び(C)フッ素イオンを含有し、(C)成分の含有量が0.0001~0.27質量%であり、(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000である口腔用組成物が、製剤の外観安定性が経時でも優れ、また、使用感(渋味・苦味・異味のなさ)も良好であることを見出し、本発明をなすに至った。
As a result of diligent studies to achieve the above object, the present inventor has further added fluoride ions to the oral composition containing both hinokitiol and ascorbic acid phosphate ester or salts thereof, both of which have coloring problems. It was found that, when blended in a specific amount and proportion, coloring was suppressed, and the appearance of liquid separation by the combined use system was prevented, excellent appearance stability was given over time, and a good feeling of use could be imparted. . That is, in the present invention, it contains (A) hinokitiol, (B) ascorbic acid phosphate ester or salt thereof, and (C) fluorine ion, and the content of (C) component is 0.0001 to 0.27% by mass. The composition for oral cavity in which ((A) + (B)) / (C) indicating the blending ratio of the components (A) and (B) to the component (C) is 0.5 to 11,000 as a mass ratio The product was found to have excellent appearance stability over time and good usability (astringency, bitterness, tastelessness) and led to the present invention.
更に詳述すると、本発明者が、ヒノキチオールにアスコルビン酸エステル又はその塩を併用して口腔用組成物に配合したところ、両者が相互作用することでコンプレックスを形成し、これにより、製剤の変色及び液分離が増悪した。また、前記両者の併用によって、渋味・苦味・異味が強く発現して味が悪くなるという、新たな問題が発生した。そこで、本発明者は、上記問題を解決するため更に検討を進めた結果、(A)、(B)成分の併用系に(C)成分を組み合わせると、(C)成分の含有量及び((A)+(B))/(C)の質量比が特定範囲内で、製剤変色及び液分離が経時でも抑制され、また、味も改善した。特に、(A)成分と(C)成分を配合しただけでは達成されない変色の課題を、同じ変色課題を有する(B)成分を含めた三成分系とすることで解決できるという、特異的かつ格別な作用効果を与えることができた。これにより、後述する実施例、比較例の結果からも明らかなように、本発明によれば、50℃で1ヶ月間保存した後にも著しい変色を発生させることなく製剤が変色するのを十分に抑える優れた変色抑制効果及び50℃で1ヶ月間保存後にも収容した容器から押し出した時に1cm以上という著しい液分離を発生させることなく十分に抑制する優れた液分離抑制効果を与え、また、(A)、(B)成分の併用によって生じる渋味・苦味・異味を抑制して味の良い使用感を付与できる。
More specifically, when the present inventor combined hinokitiol with an ascorbic acid ester or a salt thereof in an oral composition, a complex was formed by the interaction between the two, thereby causing discoloration of the preparation and Liquid separation deteriorated. In addition, the combined use of the two causes a new problem that astringency, bitterness, and off-taste are strongly expressed and the taste deteriorates. Therefore, as a result of further investigation to solve the above problems, the present inventor has combined the component (C) with the combination system of the components (A) and (B), and the content of the component (C) and (( The mass ratio of A) + (B)) / (C) was within a specific range, and the discoloration and liquid separation of the preparation were suppressed over time, and the taste was also improved. In particular, the unique and exceptional problem that the problem of discoloration that cannot be achieved simply by blending the (A) component and the (C) component can be solved by using a three-component system including the (B) component having the same discoloration problem. It was possible to give a good effect. Thereby, as is clear from the results of Examples and Comparative Examples described later, according to the present invention, it is sufficient that the preparation is discolored without causing significant discoloration even after storage at 50 ° C. for 1 month. An excellent discoloration suppressing effect that suppresses and an excellent liquid separation suppressing effect that sufficiently suppresses without causing significant liquid separation of 1 cm or more when extruded from a container accommodated even after storage at 50 ° C. for 1 month, and ( Astringent taste, bitter taste, and off-flavor produced by the combined use of components A) and (B) can be suppressed to give a good feeling of use.
従って、本発明は、
〔I〕(A)ヒノキチオール、
(B)アスコルビン酸リン酸エステル又はその塩、
(C)フッ素イオン
を含有し、(C)成分の含有量が0.0001~0.27質量%であり、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000であることを特徴とする口腔用組成物、及び
〔II〕(A)ヒノキチオール及び(B)アスコルビン酸リン酸エステル又はその塩を配合した口腔用組成物に、(C)フッ素イオンを0.0001~0.27質量%、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000の範囲内で配合することを特徴とする、前記口腔用組成物における(A)及び(B)成分による製剤変色及び液分離の抑制方法
を提供する。 Therefore, the present invention
[I] (A) Hinokitiol,
(B) Ascorbic acid phosphate or a salt thereof,
(C) Fluorine ions are contained, the content of component (C) is 0.0001 to 0.27% by mass, and the blending ratio of components (A) and (B) to component (C) is shown (( A composition for oral cavity, wherein A) + (B)) / (C) is a mass ratio of 0.5 to 11,000, and [II] (A) hinokitiol and (B) ascorbic acid phosphate An oral composition containing an ester or a salt thereof, (C) 0.0001 to 0.27% by mass of fluorine ions, and the blending ratio of the components (A) and (B) to the component (C) (( A preparation comprising the components (A) and (B) in the composition for oral cavity, wherein A) + (B)) / (C) is blended in a mass ratio of 0.5 to 11,000. A method for suppressing discoloration and liquid separation is provided.
〔I〕(A)ヒノキチオール、
(B)アスコルビン酸リン酸エステル又はその塩、
(C)フッ素イオン
を含有し、(C)成分の含有量が0.0001~0.27質量%であり、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000であることを特徴とする口腔用組成物、及び
〔II〕(A)ヒノキチオール及び(B)アスコルビン酸リン酸エステル又はその塩を配合した口腔用組成物に、(C)フッ素イオンを0.0001~0.27質量%、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000の範囲内で配合することを特徴とする、前記口腔用組成物における(A)及び(B)成分による製剤変色及び液分離の抑制方法
を提供する。 Therefore, the present invention
[I] (A) Hinokitiol,
(B) Ascorbic acid phosphate or a salt thereof,
(C) Fluorine ions are contained, the content of component (C) is 0.0001 to 0.27% by mass, and the blending ratio of components (A) and (B) to component (C) is shown (( A composition for oral cavity, wherein A) + (B)) / (C) is a mass ratio of 0.5 to 11,000, and [II] (A) hinokitiol and (B) ascorbic acid phosphate An oral composition containing an ester or a salt thereof, (C) 0.0001 to 0.27% by mass of fluorine ions, and the blending ratio of the components (A) and (B) to the component (C) (( A preparation comprising the components (A) and (B) in the composition for oral cavity, wherein A) + (B)) / (C) is blended in a mass ratio of 0.5 to 11,000. A method for suppressing discoloration and liquid separation is provided.
本発明によれば、経時でも製剤の外観安定性が優れ、使用感(渋味・苦味・異味のなさ)も良い、ヒノキチオールとアスコルビン酸リン酸エステル又はその塩含有の口腔用組成物を提供できる。本発明の口腔用組成物は、高い歯周疾患の予防又は改善効果を有し、歯周疾患の予防又は改善用として有用である。
According to the present invention, it is possible to provide a composition for oral cavity containing hinokitiol and ascorbic acid phosphate or a salt thereof, which has excellent appearance stability over time and good usability (astringency, bitterness, tastelessness). . The oral composition of the present invention has a high preventive or ameliorating effect on periodontal diseases, and is useful for preventing or improving periodontal diseases.
以下、本発明につき更に詳述する。本発明の口腔用組成物は、(A)ヒノキチオール、(B)アスコルビン酸リン酸エステル又はその塩、(C)フッ素イオンを含有する。
Hereinafter, the present invention will be described in further detail. The composition for oral cavity of this invention contains (A) hinokitiol, (B) ascorbic acid phosphate ester or its salt, and (C) fluorine ion.
(A)ヒノキチオールは、天然樹木である青森ヒバに含まれる特有成分であって、結晶性酸性化合物である。ヒノキチオールを含有する他の樹種としては、台湾ヒノキ、北米のウエスタンレッドシダー等が挙げられる。ヒノキチオールは、強い抗菌活性と広い抗菌スペクトルを有し、数少ない天然系殺菌剤のひとつであり、歯周疾患の予防又は改善効果を有する。また、ヒノキチオールは、化学合成品もあり、本発明では天然物を使用してもよいし合成品を使用してもよい。このようなヒノキチオールは、食品や化粧品をはじめ、医薬品、農芸用品、建築材料、餌類など広く一般的に使用されるものであり、本発明では、これらに使用されている市販品を用いることができる。
(A) Hinokitiol is a unique component contained in Aomori Hiba, a natural tree, and is a crystalline acidic compound. Other tree species containing hinokitiol include Taiwan cypress, North American Western red cedar and the like. Hinokitiol has strong antibacterial activity and a broad antibacterial spectrum, is one of the few natural fungicides, and has an effect of preventing or improving periodontal diseases. In addition, hinokitiol includes a chemically synthesized product, and in the present invention, a natural product or a synthetic product may be used. Such hinokitiol is widely used in foods, cosmetics, pharmaceuticals, agricultural supplies, building materials, baits, etc., and in the present invention, commercially available products used for these can be used. it can.
(A)ヒノキチオールの配合量は、組成物全体の0.005~0.5%(質量%、以下同様。)が好ましく、より好ましくは0.01~0.2%である。配合量が多いほど、歯周疾患の予防又は改善効果は高まるが、0.5%以下であると、使用感(渋味・苦味・異味のなさ)を十分かつ良好に維持できる。
(A) The amount of hinokitiol is preferably 0.005 to 0.5% (mass%, the same applies hereinafter) of the whole composition, more preferably 0.01 to 0.2%. As the blending amount increases, the effect of preventing or improving periodontal disease increases, but when it is 0.5% or less, the feeling of use (astringency, bitterness, and taste) can be maintained sufficiently and satisfactorily.
(B)アスコルビン酸リン酸エステルとしては、アスコルビン酸の2,3,5,6位のいずれかの水酸基の1つ又は2つ以上がリン酸エステルになったもの、例えば、アスコルビン酸-2-リン酸エステル、アスコルビン酸-3-リン酸エステル、アスコルビン酸-6-リン酸エステル等が挙げられる。これらの塩類としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩等が挙げられる。これらから選ばれる1種又は2種以上を、(B)アスコルビン酸リン酸エステル又はその塩として使用できる。特に、組成物の安定性の点から、アスコルビン酸の2位又は3位の水酸基がリン酸エステル化された誘導体が好ましく、より好ましくはアスコルビン酸-2-リン酸エステルのマグネシウム塩やナトリウム塩であり、とりわけ好ましくはマグネシウム塩である。
(B) Ascorbic acid phosphates include those in which one or more of the hydroxyl groups at positions 2, 3, 5, and 6 of ascorbic acid are converted to phosphates, for example, ascorbic acid-2- Examples thereof include phosphoric acid ester, ascorbic acid-3-phosphate ester, ascorbic acid-6-phosphate ester and the like. Examples of these salts include sodium salt, potassium salt, calcium salt, magnesium salt and the like. 1 type (s) or 2 or more types chosen from these can be used as (B) ascorbic acid phosphate ester or its salt. In particular, from the viewpoint of the stability of the composition, a derivative in which the hydroxyl group at the 2-position or 3-position of ascorbic acid is converted to a phosphate ester is preferable, and a magnesium salt or sodium salt of ascorbyl 2-phosphate ester is more preferable. Particularly preferred is a magnesium salt.
(B)アスコルビン酸リン酸エステル又はその塩の配合量は、組成物全体の0.1~5%が好ましく、より好ましくは0.2~4%である。0.1%以上にすると、本発明の変色、液分離の抑制効果が特に優れる。5%以下であると、変色、液分離の抑制効果が特に良好である。
(B) The blending amount of ascorbic acid phosphate or a salt thereof is preferably 0.1 to 5%, more preferably 0.2 to 4% of the entire composition. When it is 0.1% or more, the effect of suppressing discoloration and liquid separation of the present invention is particularly excellent. When it is 5% or less, the effect of suppressing discoloration and liquid separation is particularly good.
(C)フッ素イオンは、フッ素イオンを供給するフッ素含有化合物として配合することができる。フッ素含有化合物としては、フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等が挙げられ、これらから選ばれる1種又は2種以上を用いることができる。特に、本発明の効果付与の点から、フッ化ナトリウム、モノフルオロリン酸ナトリウムが好ましく、より好ましくはモノフルオロリン酸ナトリウムである。
(C) Fluorine ions can be blended as a fluorine-containing compound that supplies fluorine ions. Examples of the fluorine-containing compound include sodium fluoride, sodium monofluorophosphate, tin fluoride and the like, and one or more selected from these can be used. In particular, sodium fluoride and sodium monofluorophosphate are preferable from the viewpoint of imparting the effect of the present invention, and sodium monofluorophosphate is more preferable.
(C)フッ素イオンの配合量は、組成物全体の0.0001~0.27%であり、好ましくは0.001~0.19%である。前記フッ素イオンの配合量の範囲内で、フッ素含有化合物が配合され、その配合量はフッ素イオン量から換算して求めることができる。例えば、モノフルオロリン酸ナトリウムの場合、その好ましい配合量は組成物全体の0.001~2%、特に0.01~1.4%である。フッ化ナトリウムの場合、その好ましい配合量は組成物全体の0.0003~0.58%、特に0.001~0.41%である。
(C)フッ素イオンの配合量が上記範囲内であると、製剤の変色抑制効果及び液分離抑制効果が優れ、使用感(渋味・苦味・異味のなさ)が向上する。0.0001%に満たないと、変色抑制効果又は分離抑制効果が満足に得られず、使用感(渋味・苦味・異味のなさ)が劣る。0.27%を超えると、液分離抑制効果が低下したり、使用感(渋味・苦味・異味のなさ)が劣る。 The blending amount of (C) fluorine ions is 0.0001 to 0.27%, preferably 0.001 to 0.19% of the entire composition. The fluorine-containing compound is blended within the range of the blending amount of the fluorine ions, and the blending amount can be obtained by conversion from the fluorine ion amount. For example, in the case of sodium monofluorophosphate, the preferable blending amount is 0.001 to 2%, particularly 0.01 to 1.4% of the whole composition. In the case of sodium fluoride, the preferred blending amount is 0.0003 to 0.58%, particularly 0.001 to 0.41% of the entire composition.
(C) When the compounding quantity of a fluorine ion is in the above range, the discoloration suppressing effect and the liquid separation suppressing effect of the preparation are excellent, and the feeling of use (astringency, bitterness, tastelessness) is improved. If it is less than 0.0001%, the discoloration suppressing effect or the separation suppressing effect cannot be obtained satisfactorily, and the feeling of use (astringency, bitterness, tastelessness) is inferior. If it exceeds 0.27%, the effect of suppressing liquid separation is lowered, and the feeling of use (astringency, bitterness, tastelessness) is inferior.
(C)フッ素イオンの配合量が上記範囲内であると、製剤の変色抑制効果及び液分離抑制効果が優れ、使用感(渋味・苦味・異味のなさ)が向上する。0.0001%に満たないと、変色抑制効果又は分離抑制効果が満足に得られず、使用感(渋味・苦味・異味のなさ)が劣る。0.27%を超えると、液分離抑制効果が低下したり、使用感(渋味・苦味・異味のなさ)が劣る。 The blending amount of (C) fluorine ions is 0.0001 to 0.27%, preferably 0.001 to 0.19% of the entire composition. The fluorine-containing compound is blended within the range of the blending amount of the fluorine ions, and the blending amount can be obtained by conversion from the fluorine ion amount. For example, in the case of sodium monofluorophosphate, the preferable blending amount is 0.001 to 2%, particularly 0.01 to 1.4% of the whole composition. In the case of sodium fluoride, the preferred blending amount is 0.0003 to 0.58%, particularly 0.001 to 0.41% of the entire composition.
(C) When the compounding quantity of a fluorine ion is in the above range, the discoloration suppressing effect and the liquid separation suppressing effect of the preparation are excellent, and the feeling of use (astringency, bitterness, tastelessness) is improved. If it is less than 0.0001%, the discoloration suppressing effect or the separation suppressing effect cannot be obtained satisfactorily, and the feeling of use (astringency, bitterness, tastelessness) is inferior. If it exceeds 0.27%, the effect of suppressing liquid separation is lowered, and the feeling of use (astringency, bitterness, tastelessness) is inferior.
本発明において、(C)成分のフッ素イオンの配合量に対する(A)及び(B)成分の合計配合量の割合を示す((A)+(B))/(C)は、質量比として0.5~11,000であり、好ましくは0.6~10,500、より好ましくは1.2~4,200である。この範囲内であると、製剤の変色抑制効果及び液分離抑制効果が優れ、使用感(渋味・苦味・異味のなさ)が優れる。((A)+(B))/(C)が0.5に満たないと、液分離抑制効果が低下し、使用感(渋味・苦味・異味のなさ)が劣る。11,000を超えると、製剤の変色抑制効果及び液分離抑制効果が低下し、使用感(渋味・苦味・異味のなさ)が劣る。
In the present invention, ((A) + (B)) / (C) indicating the ratio of the total blending amount of the components (A) and (B) to the blending amount of the fluorine ion of the component (C) is 0 as a mass ratio. 0.5 to 11,000, preferably 0.6 to 10,500, more preferably 1.2 to 4,200. Within this range, the discoloration-suppressing effect and liquid separation-suppressing effect of the preparation are excellent, and the feeling of use (astringency, bitterness, tastelessness) is excellent. If ((A) + (B)) / (C) is less than 0.5, the effect of suppressing liquid separation is reduced, and the feeling of use (astringency, bitterness, and taste) is inferior. If it exceeds 11,000, the discoloration suppressing effect and the liquid separation suppressing effect of the preparation are lowered, and the feeling of use (astringency, bitterness, tastelessness) is inferior.
本発明の口腔用組成物は、その形状、剤型は制限されないが、特に、ペースト状、ゲル状等の半固体形状に調製して練歯磨、ゲル状歯磨等の歯磨剤として、とりわけ練歯磨として好適に調製できる。
The oral composition of the present invention is not limited in its shape and dosage form, but in particular, it is prepared in a semi-solid form such as paste or gel and used as a dentifrice such as toothpaste or gel toothpaste, especially toothpaste. Can be suitably prepared.
本発明の口腔用組成物には、上記各成分に加えて、本発明の効果を損なわない範囲において、剤型等に応じた公知の口腔用の添加成分(薬理学的に許容される担体)を配合できる。かかる添加成分として、歯磨剤では、例えば研磨剤、粘結剤、界面活性剤、湿潤剤、着色剤、防腐剤、甘味剤、香料、pH調整剤、(A),(B),(C)成分以外の有効成分などが挙げられる。以下に添加成分の具体例を示すが、本発明の口腔用組成物に配合可能な成分はこれらに制限されるものではない。
In the composition for oral cavity of the present invention, in addition to the above-mentioned components, known oral additive components (pharmacologically acceptable carriers) according to the dosage form and the like within a range not impairing the effects of the present invention Can be blended. As an additive component, in dentifrices, for example, abrasives, binders, surfactants, wetting agents, coloring agents, preservatives, sweeteners, fragrances, pH adjusters, (A), (B), (C) Examples include active ingredients other than the ingredients. Although the specific example of an additional component is shown below, the component which can be mix | blended with the composition for oral cavity of this invention is not restrict | limited to these.
研磨剤としては、シリカゲル、沈降シリカ、無水ケイ酸、アルミノシリケート、ジルコノシリケート等のシリカ系研磨剤、ピロリン酸カルシウム、炭酸カルシウム、水酸化アルミニウム、アルミナ、炭酸マグネシウム、第3リン酸マグネシウム、ゼオライト、ケイ酸ジルコニウム、ハイドロキシアパタイト、合成樹脂系研磨剤などが挙げられる。研磨剤の配合量は通常、組成物全体の2~40%、特に10~25%である。
なお、本発明では、特に製剤の変色抑制の点で、研磨剤としてはシリカ系研磨剤が好適であり、特に主研磨剤はシリカ系研磨剤が好ましい。また、シリカ系以外の研磨剤は配合しなくてもよいが、配合する場合はその配合量が10%以下、特に1~8%が好ましく、配合しないこと(0%)がより好ましい。 As abrasives, silica-based abrasives such as silica gel, precipitated silica, anhydrous silicic acid, aluminosilicate, zirconosilicate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tribasic magnesium phosphate, zeolite, Examples thereof include zirconium silicate, hydroxyapatite, and a synthetic resin abrasive. The blending amount of the abrasive is usually 2 to 40%, particularly 10 to 25% of the whole composition.
In the present invention, a silica-based abrasive is preferred as the abrasive, particularly in terms of suppressing discoloration of the preparation, and a silica-based abrasive is particularly preferred as the main abrasive. Further, abrasives other than silica-based abrasives may not be blended, but when blended, the blending amount is 10% or less, particularly 1 to 8% is preferable, and not blended (0%) is more preferable.
なお、本発明では、特に製剤の変色抑制の点で、研磨剤としてはシリカ系研磨剤が好適であり、特に主研磨剤はシリカ系研磨剤が好ましい。また、シリカ系以外の研磨剤は配合しなくてもよいが、配合する場合はその配合量が10%以下、特に1~8%が好ましく、配合しないこと(0%)がより好ましい。 As abrasives, silica-based abrasives such as silica gel, precipitated silica, anhydrous silicic acid, aluminosilicate, zirconosilicate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tribasic magnesium phosphate, zeolite, Examples thereof include zirconium silicate, hydroxyapatite, and a synthetic resin abrasive. The blending amount of the abrasive is usually 2 to 40%, particularly 10 to 25% of the whole composition.
In the present invention, a silica-based abrasive is preferred as the abrasive, particularly in terms of suppressing discoloration of the preparation, and a silica-based abrasive is particularly preferred as the main abrasive. Further, abrasives other than silica-based abrasives may not be blended, but when blended, the blending amount is 10% or less, particularly 1 to 8% is preferable, and not blended (0%) is more preferable.
粘結剤としては、ポリアクリル酸ナトリウム、キサンタンガム、グアガム等のガム類、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシメチルエチルセルロース、メチルセルロース、カチオン化セルロース等のセルロース誘導体、カラギーナン、アルギン酸ナトリウム、モンモリロナイト、ゼラチンなどが挙げられる。中でも、液分離抑制効果の発現性の点から、キサンタンガム、ポリアクリル酸ナトリウムから選ばれる1種又は2種が好ましい。粘結剤の配合量は通常、組成物全体の0.1~10%、特に0.5~5%である。
As a binder, gums such as sodium polyacrylate, xanthan gum, guar gum, carboxymethylcellulose sodium, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxymethylethylcellulose, methylcellulose, cellulose derivatives such as cationized cellulose, carrageenan, Examples include sodium alginate, montmorillonite, and gelatin. Especially, the 1 type or 2 types chosen from a xanthan gum and a sodium polyacrylate from the point of the expression of the liquid-separation inhibitory effect is preferable. The amount of the binder is usually 0.1 to 10%, particularly 0.5 to 5% of the whole composition.
界面活性剤としては、アニオン性界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、両イオン性界面活性剤が使用でき、具体的には下記が挙げられる。
アニオン性界面活性剤:ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫酸エステル塩、ドデシルベンゼンスルホン酸ナトリウム、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウム、α-オレフィンスルホン酸ナトリウム、ラウロイルサルコシンナトリウム、ラウロイルメチルタウリン等のアシルアミノ酸塩、α-スルホ脂肪酸アルキルエステル・ナトリウム、アルキルリン酸エステル塩
カチオン性界面活性剤:塩化ジステアリルメチルアンモニウム、塩化ステアリルジメチルベンジルアンモニウム
非イオン性界面活性剤:ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エステル等の糖アルコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリエチレングリコール脂肪酸エステル等の多価アルコール脂肪酸エステル、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油などのエーテル型の界面活性剤、ラウリン酸ジエタノールアミド等の脂肪酸アルカノールアミド
両イオン性界面活性剤:2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリウムベタイン等のイミダゾリウムベタイン系、N-ラウリルジアミノエチルグリシン、N-ミリスチルジアミノエチルグリシン等のN-アルキルジアミノエチルグリシン
界面活性剤の配合量は通常、組成物全体の0.2~15%、特に0.5~10%である。 As the surfactant, an anionic surfactant, a cationic surfactant, a nonionic surfactant, and an amphoteric surfactant can be used. Specific examples include the following.
Anionic surfactants: alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate, sodium α-olefin sulfonate, sodium lauroyl sarcosine , Acylamino acid salts such as lauroylmethyltaurine, α-sulfo fatty acid alkyl ester / sodium, alkyl phosphate ester cationic surfactant: distearylmethylammonium chloride, stearyldimethylbenzylammonium chloride Nonionic surfactant: sorbitan fatty acid Esters, sugar alcohol fatty acid esters such as polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, glycerin fat Esters, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyhydric alcohol fatty acid esters such as polyethylene glycol fatty acid esters, polyoxyethylene polyoxypropylene copolymers, polyoxyethylene alkylphenyl ether, polyoxyethylene alkyl ether, poly Ether type surfactants such as oxyethylene hydrogenated castor oil, fatty acid alkanolamides such as lauric acid diethanolamide Amphoteric surfactants: imidazoliums such as 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolium betaine N-alkyldiaminoethylglycine surfactant content such as betaine, N-lauryldiaminoethylglycine, N-myristyldiaminoethylglycine, etc. 0.2 to 15%, especially 0.5 to 10% of the total composition.
アニオン性界面活性剤:ラウリル硫酸ナトリウム、ミリスチル硫酸ナトリウム等のアルキル硫酸エステル塩、ドデシルベンゼンスルホン酸ナトリウム、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウム、α-オレフィンスルホン酸ナトリウム、ラウロイルサルコシンナトリウム、ラウロイルメチルタウリン等のアシルアミノ酸塩、α-スルホ脂肪酸アルキルエステル・ナトリウム、アルキルリン酸エステル塩
カチオン性界面活性剤:塩化ジステアリルメチルアンモニウム、塩化ステアリルジメチルベンジルアンモニウム
非イオン性界面活性剤:ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ショ糖脂肪酸エステル等の糖アルコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリエチレングリコール脂肪酸エステル等の多価アルコール脂肪酸エステル、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油などのエーテル型の界面活性剤、ラウリン酸ジエタノールアミド等の脂肪酸アルカノールアミド
両イオン性界面活性剤:2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリウムベタイン等のイミダゾリウムベタイン系、N-ラウリルジアミノエチルグリシン、N-ミリスチルジアミノエチルグリシン等のN-アルキルジアミノエチルグリシン
界面活性剤の配合量は通常、組成物全体の0.2~15%、特に0.5~10%である。 As the surfactant, an anionic surfactant, a cationic surfactant, a nonionic surfactant, and an amphoteric surfactant can be used. Specific examples include the following.
Anionic surfactants: alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sodium dodecylbenzene sulfonate, hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate, sodium α-olefin sulfonate, sodium lauroyl sarcosine , Acylamino acid salts such as lauroylmethyltaurine, α-sulfo fatty acid alkyl ester / sodium, alkyl phosphate ester cationic surfactant: distearylmethylammonium chloride, stearyldimethylbenzylammonium chloride Nonionic surfactant: sorbitan fatty acid Esters, sugar alcohol fatty acid esters such as polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, glycerin fat Esters, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyhydric alcohol fatty acid esters such as polyethylene glycol fatty acid esters, polyoxyethylene polyoxypropylene copolymers, polyoxyethylene alkylphenyl ether, polyoxyethylene alkyl ether, poly Ether type surfactants such as oxyethylene hydrogenated castor oil, fatty acid alkanolamides such as lauric acid diethanolamide Amphoteric surfactants: imidazoliums such as 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolium betaine N-alkyldiaminoethylglycine surfactant content such as betaine, N-lauryldiaminoethylglycine, N-myristyldiaminoethylglycine, etc. 0.2 to 15%, especially 0.5 to 10% of the total composition.
湿潤剤としては、プロピレングリコール、ペンチレングリコール、ヘキシレングリコール、オクチレングリコール、平均分子量200~6,000(医薬部外品原料規格2006記載の平均分子量)のポリエチレングリコール、エチレングリコール、1,3-ブチレングリコール、グリセリン等の多価アルコール、ソルビット、キシリトール、エリスリトール、還元でんぷん糖化物等の糖アルコールなどが挙げられる。湿潤剤の配合量は通常、組成物全体の5~50%、特に20~45%である。
Examples of the wetting agent include propylene glycol, pentylene glycol, hexylene glycol, octylene glycol, polyethylene glycol having an average molecular weight of 200 to 6,000 (average molecular weight described in Quasi-drug Raw Material Standard 2006), ethylene glycol, 1,3 -Polyhydric alcohols such as butylene glycol and glycerin, sugar alcohols such as sorbitol, xylitol, erythritol, and reduced starch saccharified product. The amount of the wetting agent is usually 5 to 50%, particularly 20 to 45% of the whole composition.
着色剤としては、青色1号、黄色4号、緑色3号等の法定色素、カラメル等の天然色素、酸化チタンなど、防腐剤としては、パラオキシ安息香酸エステル又はその塩、安息香酸又はその塩などが挙げられる。
甘味剤としては、サッカリンナトリウム、アスパラテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジルジヒドロカルコン、ぺリラルチンなどが挙げられる。 As colorants, legal dyes such as blue No. 1, yellow No. 4 and green No. 3, natural dyes such as caramel, titanium oxide, etc., as preservatives, paraoxybenzoic acid esters or salts thereof, benzoic acid or salts thereof, etc. Is mentioned.
Examples of the sweetening agent include saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perilartin and the like.
甘味剤としては、サッカリンナトリウム、アスパラテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジルジヒドロカルコン、ぺリラルチンなどが挙げられる。 As colorants, legal dyes such as blue No. 1, yellow No. 4 and green No. 3, natural dyes such as caramel, titanium oxide, etc., as preservatives, paraoxybenzoic acid esters or salts thereof, benzoic acid or salts thereof, etc. Is mentioned.
Examples of the sweetening agent include saccharin sodium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perilartin and the like.
香料としては、口腔用香料として公知のものを使用できる。例えば、メントール、アネトール、カルボン、オイゲノール、リモネン、n-デシルアルコール、シトロネロール、α-テレピネオール、シトロネリルアセテート、シネオール、リナロール、エチルリナロール、ワニリン、チモール、スペアミント油、ペパーミント油、レモン油、オレンジ油、セージ油、ローズマリー油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油、丁字油、ユーカリ油などが挙げられる。香料の配合量は、組成物全体の0.000001~2%が好ましい。
As the fragrance, those known as oral fragrances can be used. For example, menthol, anethole, carvone, eugenol, limonene, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, linalool, ethyl linalool, vanillin, thymol, spearmint oil, peppermint oil, lemon oil, orange oil, Examples include sage oil, rosemary oil, cinnamon oil, pimento oil, cinnamon oil, perilla oil, winter green oil, clove oil, eucalyptus oil and the like. The blending amount of the fragrance is preferably 0.000001 to 2% of the entire composition.
pH調整剤としては、クエン酸、乳酸、リンゴ酸等の有機酸及びその塩類、塩酸、水酸化ナトリウム、水酸化カリウム、リン酸水素二ナトリウム、リン酸二水素ナトリウム等の無機化合物などが挙げられる。
なお、組成物のpH(25℃)は、特に(B)成分の安定性の点から、好ましくは8以上、特に8.1~9.3である。 Examples of the pH adjuster include organic acids such as citric acid, lactic acid, malic acid and salts thereof, and inorganic compounds such as hydrochloric acid, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, and the like. .
The pH (25 ° C.) of the composition is preferably 8 or more, particularly 8.1 to 9.3, particularly from the viewpoint of the stability of the component (B).
なお、組成物のpH(25℃)は、特に(B)成分の安定性の点から、好ましくは8以上、特に8.1~9.3である。 Examples of the pH adjuster include organic acids such as citric acid, lactic acid, malic acid and salts thereof, and inorganic compounds such as hydrochloric acid, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, and the like. .
The pH (25 ° C.) of the composition is preferably 8 or more, particularly 8.1 to 9.3, particularly from the viewpoint of the stability of the component (B).
本発明の口腔用組成物には、溶剤として水が用いられる。なお、エタノール等の低級一価アルコールは1~10%程度配合してもよいが、配合しなくても(0%)よい。水の量は、特に制限はなく、通常、5~95質量%の範囲とすることができる。特に、本発明の口腔用組成物が歯磨剤の場合は、好ましくは5~70%、より好ましくは10~60%とすることができる。
In the oral composition of the present invention, water is used as a solvent. The lower monohydric alcohol such as ethanol may be added in an amount of about 1 to 10%, but may not be added (0%). The amount of water is not particularly limited, and can usually be in the range of 5 to 95% by mass. In particular, when the oral composition of the present invention is a dentifrice, it can be preferably 5 to 70%, more preferably 10 to 60%.
以下、実施例及び比較例、処方例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において%は特に断らない限りいずれも質量%を示す。
Hereinafter, although an Example, a comparative example, and a formulation example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples, “%” means “% by mass” unless otherwise specified.
[実施例、比較例]
表1、2に示す組成の口腔用組成物(練歯磨)を常法によって調製し、下記方法で評価した。結果を表に併記した。
なお、表中の((A)+(B))/(C)は、(C)成分のフッ素イオンの配合量に対する(A)及び(B)成分の合計配合量の割合を示す質量比である(以下同様。)。
各組成物のpH(25℃)は8.1~9.3の範囲内に調整した(以下同様。)。
また、実施例の口腔用組成物は、いずれも(A)、(B)成分が有効に作用して薬効が十分に発揮され、高い歯周疾患の予防又は改善効果を有することを確認した。 [Examples and Comparative Examples]
Oral compositions (toothpaste) having the compositions shown in Tables 1 and 2 were prepared by a conventional method and evaluated by the following methods. The results are shown in the table.
In addition, ((A) + (B)) / (C) in the table is a mass ratio indicating the ratio of the total blending amount of the (A) and (B) components to the blending amount of the fluorine ions of the (C) component. Yes (the same applies below).
The pH (25 ° C.) of each composition was adjusted within the range of 8.1 to 9.3 (the same applies hereinafter).
In addition, it was confirmed that the compositions for oral cavity of the Examples all have the effects of the (A) and (B) components effectively acting to sufficiently exhibit the medicinal effects, and have a high periodontal disease prevention or improvement effect.
表1、2に示す組成の口腔用組成物(練歯磨)を常法によって調製し、下記方法で評価した。結果を表に併記した。
なお、表中の((A)+(B))/(C)は、(C)成分のフッ素イオンの配合量に対する(A)及び(B)成分の合計配合量の割合を示す質量比である(以下同様。)。
各組成物のpH(25℃)は8.1~9.3の範囲内に調整した(以下同様。)。
また、実施例の口腔用組成物は、いずれも(A)、(B)成分が有効に作用して薬効が十分に発揮され、高い歯周疾患の予防又は改善効果を有することを確認した。 [Examples and Comparative Examples]
Oral compositions (toothpaste) having the compositions shown in Tables 1 and 2 were prepared by a conventional method and evaluated by the following methods. The results are shown in the table.
In addition, ((A) + (B)) / (C) in the table is a mass ratio indicating the ratio of the total blending amount of the (A) and (B) components to the blending amount of the fluorine ions of the (C) component. Yes (the same applies below).
The pH (25 ° C.) of each composition was adjusted within the range of 8.1 to 9.3 (the same applies hereinafter).
In addition, it was confirmed that the compositions for oral cavity of the Examples all have the effects of the (A) and (B) components effectively acting to sufficiently exhibit the medicinal effects, and have a high periodontal disease prevention or improvement effect.
(1)変色の評価方法
口径8mmのラミネートチューブに充填した口腔用組成物の各組成3本ずつを50℃で1ヶ月間又は-5℃で1ヶ月間保存した後、わら半紙上に口腔用組成物を10cm押し出し、被験者の専門家パネラー5名が-5℃保存品に比べた50℃保存品の色調変化を観察し、下記の4段階の評点基準に従って官能評価した。3本についての5名の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを、経時においても製剤の変色が抑制され合格であるとした。
変色の評点基準
4点:変色がまったくない
3点:変色がほとんどない
2点:変色が認められる
1点:著しく変色が認められる
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (1) Discoloration evaluation method Three oral compositions filled in an 8 mm diameter laminated tube were stored at 50 ° C. for 1 month or −5 ° C. for 1 month, and then the oral composition on a straw half paper. The object was extruded 10 cm, and five expert panelists of the test subjects observed changes in color tone of the product stored at 50 ° C. compared to the product stored at −5 ° C., and sensory evaluation was performed according to the following four grades. The average value of the score results of five people for three was obtained and judged according to the following evaluation criteria. ○ The above was deemed acceptable because discoloration of the preparation was suppressed over time.
4 points: no discoloration 3 points: almost no discoloration 2 points: discoloration observed 1 point: remarkably discoloration evaluation criteria ◎: 3.5 points or more and 4.0 points or less ○: 3 0 point or more and less than 3.5 point △: 2.0 point or more and less than 3.0 point ×: Less than 2.0 point
口径8mmのラミネートチューブに充填した口腔用組成物の各組成3本ずつを50℃で1ヶ月間又は-5℃で1ヶ月間保存した後、わら半紙上に口腔用組成物を10cm押し出し、被験者の専門家パネラー5名が-5℃保存品に比べた50℃保存品の色調変化を観察し、下記の4段階の評点基準に従って官能評価した。3本についての5名の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを、経時においても製剤の変色が抑制され合格であるとした。
変色の評点基準
4点:変色がまったくない
3点:変色がほとんどない
2点:変色が認められる
1点:著しく変色が認められる
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (1) Discoloration evaluation method Three oral compositions filled in an 8 mm diameter laminated tube were stored at 50 ° C. for 1 month or −5 ° C. for 1 month, and then the oral composition on a straw half paper. The object was extruded 10 cm, and five expert panelists of the test subjects observed changes in color tone of the product stored at 50 ° C. compared to the product stored at −5 ° C., and sensory evaluation was performed according to the following four grades. The average value of the score results of five people for three was obtained and judged according to the following evaluation criteria. ○ The above was deemed acceptable because discoloration of the preparation was suppressed over time.
4 points: no discoloration 3 points: almost no discoloration 2 points: discoloration observed 1 point: remarkably discoloration evaluation criteria ◎: 3.5 points or more and 4.0 points or less ○: 3 0 point or more and less than 3.5 point △: 2.0 point or more and less than 3.0 point ×: Less than 2.0 point
(2)液分離の評価方法
口径8mmのラミネートチューブに充填した口腔用組成物の各組成3本を50℃で1ヶ月間保存した後、わら半紙上に口腔用組成物を10cm押し出し、わら半紙に染み出した液の長さを測定して、液分離の度合いを下記の4段階の評点基準に従って評価した。3本の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを、経時においても製剤の液分離が抑制され合格であるとした。
液分離の評点基準
4点:液分離は全く観察されない
3点:押し出した時、口元部分に液分離がほとんどなく、使用上問題ない
2点:押し出した時、口元部分に液分離が1~3cm認められる
1点:押し出した時、口元部分に液分離が3cmを超えて認められる
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (2) Evaluation method of liquid separation After storing 3 compositions of each composition for oral cavity filled in a laminate tube having a diameter of 8 mm at 50 ° C. for 1 month, the composition for oral cavity was extruded 10 cm onto a straw half paper, and the straw half paper was stained. The length of the extracted liquid was measured, and the degree of liquid separation was evaluated according to the following four grades. The average value of the three score results was obtained and judged according to the following evaluation criteria. ○ The above were deemed acceptable because liquid separation of the preparation was suppressed over time.
Criterion criteria for liquid separation 4 points: No liquid separation is observed 3 points: When extruded, there is almost no liquid separation at the mouth, and there is no problem in use 2 points: When pushed, liquid separation is 1 to 3 cm at the mouth Permitted 1 point: When extruded, liquid separation exceeds 3 cm at the mouth. Evaluation criteria ◎: 3.5 or more and 4.0 or less ○: 3.0 or more and less than 3.5 △: 2 .0 point or more and less than 3.0 point ×: less than 2.0 point
口径8mmのラミネートチューブに充填した口腔用組成物の各組成3本を50℃で1ヶ月間保存した後、わら半紙上に口腔用組成物を10cm押し出し、わら半紙に染み出した液の長さを測定して、液分離の度合いを下記の4段階の評点基準に従って評価した。3本の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを、経時においても製剤の液分離が抑制され合格であるとした。
液分離の評点基準
4点:液分離は全く観察されない
3点:押し出した時、口元部分に液分離がほとんどなく、使用上問題ない
2点:押し出した時、口元部分に液分離が1~3cm認められる
1点:押し出した時、口元部分に液分離が3cmを超えて認められる
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (2) Evaluation method of liquid separation After storing 3 compositions of each composition for oral cavity filled in a laminate tube having a diameter of 8 mm at 50 ° C. for 1 month, the composition for oral cavity was extruded 10 cm onto a straw half paper, and the straw half paper was stained. The length of the extracted liquid was measured, and the degree of liquid separation was evaluated according to the following four grades. The average value of the three score results was obtained and judged according to the following evaluation criteria. ○ The above were deemed acceptable because liquid separation of the preparation was suppressed over time.
Criterion criteria for liquid separation 4 points: No liquid separation is observed 3 points: When extruded, there is almost no liquid separation at the mouth, and there is no problem in use 2 points: When pushed, liquid separation is 1 to 3 cm at the mouth Permitted 1 point: When extruded, liquid separation exceeds 3 cm at the mouth. Evaluation criteria ◎: 3.5 or more and 4.0 or less ○: 3.0 or more and less than 3.5 △: 2 .0 point or more and less than 3.0 point ×: less than 2.0 point
(3)使用感(渋味・苦味・異味のなさ)の評価方法
被験者の専門家パネラー10名を用いた官能試験を実施した。口腔用組成物約0.5gを市販の歯ブラシにのせて3分間ブラッシングを行い、使用中に感じた渋味・苦味・異味のなさを下記の4段階の評点基準に従って官能評価した。10名の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを渋味・苦味・異味が抑えられて使用感が良く合格であるとした。
渋味・苦味・異味のなさの評点基準
4点:渋味・苦味・異味がまったくない
3点:渋味・苦味・異味がわずかにある
2点:渋味・苦味・異味がややある
1点:渋味・苦味・異味がかなりある
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (3) Evaluation method of feeling of use (astringency, bitterness, tastelessness) A sensory test was conducted using 10 expert panelists. About 0.5 g of the oral composition was placed on a commercially available toothbrush and brushed for 3 minutes, and the astringency, bitterness, and taste of taste felt during use were sensory-evaluated according to the following four grades. The average value of the score result of 10 persons was calculated | required and it determined by the following evaluation criteria. ○ The above is said to pass well, with astringent taste, bitterness and off-flavor being suppressed.
4 points: no astringency, bitterness, or off-flavor 3 points: slight astringency, bitterness, off-flavor 2 points: slightly astringency, bitterness, off-flavor 1 : Astringency, bitterness, and off-flavor are considerable. Evaluation criteria ◎: 3.5 or more and 4.0 or less ○: 3.0 or more and less than 3.5 △: 2.0 or more and less than 3.0 ×: Less than 2.0
被験者の専門家パネラー10名を用いた官能試験を実施した。口腔用組成物約0.5gを市販の歯ブラシにのせて3分間ブラッシングを行い、使用中に感じた渋味・苦味・異味のなさを下記の4段階の評点基準に従って官能評価した。10名の評点結果の平均値を求め、下記の評価基準で判定した。○以上のものを渋味・苦味・異味が抑えられて使用感が良く合格であるとした。
渋味・苦味・異味のなさの評点基準
4点:渋味・苦味・異味がまったくない
3点:渋味・苦味・異味がわずかにある
2点:渋味・苦味・異味がややある
1点:渋味・苦味・異味がかなりある
評価基準
◎:3.5点以上4.0点以下
○:3.0点以上3.5点未満
△:2.0点以上3.0点未満
×:2.0点未満 (3) Evaluation method of feeling of use (astringency, bitterness, tastelessness) A sensory test was conducted using 10 expert panelists. About 0.5 g of the oral composition was placed on a commercially available toothbrush and brushed for 3 minutes, and the astringency, bitterness, and taste of taste felt during use were sensory-evaluated according to the following four grades. The average value of the score result of 10 persons was calculated | required and it determined by the following evaluation criteria. ○ The above is said to pass well, with astringent taste, bitterness and off-flavor being suppressed.
4 points: no astringency, bitterness, or off-flavor 3 points: slight astringency, bitterness, off-flavor 2 points: slightly astringency, bitterness, off-flavor 1 : Astringency, bitterness, and off-flavor are considerable. Evaluation criteria ◎: 3.5 or more and 4.0 or less ○: 3.0 or more and less than 3.5 △: 2.0 or more and less than 3.0 ×: Less than 2.0
主な使用原料の詳細は下記の通りである。
(A)ヒノキチオール:高砂香料(株)製
(B)リン酸L-アスコルビルマグネシウム:和光純薬工業(株)製、生化学用
(C)モノフルオロリン酸ナトリウム:ローディア日華(株)製
(C)フッ化ナトリウム:ステラケミファ(株)製、フッ化ナトリウム Details of the main raw materials used are as follows.
(A) Hinokitiol: Takasago Fragrance Co., Ltd. (B) L-Ascorbyl Magnesium Phosphate: Wako Pure Chemical Industries, Biochemical (C) Sodium Monofluorophosphate: Rhodia Nikka Co., Ltd. ( C) Sodium fluoride: sodium fluoride manufactured by Stella Chemifa Corporation
(A)ヒノキチオール:高砂香料(株)製
(B)リン酸L-アスコルビルマグネシウム:和光純薬工業(株)製、生化学用
(C)モノフルオロリン酸ナトリウム:ローディア日華(株)製
(C)フッ化ナトリウム:ステラケミファ(株)製、フッ化ナトリウム Details of the main raw materials used are as follows.
(A) Hinokitiol: Takasago Fragrance Co., Ltd. (B) L-Ascorbyl Magnesium Phosphate: Wako Pure Chemical Industries, Biochemical (C) Sodium Monofluorophosphate: Rhodia Nikka Co., Ltd. ( C) Sodium fluoride: sodium fluoride manufactured by Stella Chemifa Corporation
以下に処方例を示す。
A prescription example is shown below.
[処方例1]練歯磨剤
(A)ヒノキチオール 0.1%
(B)リン酸L-アスコルビルマグネシウム 0.3
(C)モノフルオロリン酸ナトリウム 0.73
フッ素イオン量 0.096
無水ケイ酸(研磨剤) 12
ソルビット液(70%) 40
サッカリンナトリウム 0.2
増粘性シリカ 6
酸化チタン 0.5
プロピレングリコール 3
キサンタンガム 0.7
ポリアクリル酸ナトリウム 0.4
クエン酸 0.1
水酸化ナトリウム 0.1
ラウリル硫酸ナトリウム 1.5
香料 0.8
精製水 バランス
合計 100.0%
((A)+(B))/(C)=4.2 [Prescription Example 1] Toothpaste (A) Hinokitiol 0.1%
(B) L-ascorbyl magnesium phosphate 0.3
(C) Sodium monofluorophosphate 0.73
Fluorine ion content 0.096
Silicic anhydride (abrasive) 12
Sorbit liquid (70%) 40
Saccharin sodium 0.2
Thickening silica 6
Titanium oxide 0.5
Propylene glycol 3
Xanthan gum 0.7
Sodium polyacrylate 0.4
Citric acid 0.1
Sodium hydroxide 0.1
Sodium lauryl sulfate 1.5
Fragrance 0.8
Purified water balance
Total 100.0%
((A) + (B)) / (C) = 4.2
(A)ヒノキチオール 0.1%
(B)リン酸L-アスコルビルマグネシウム 0.3
(C)モノフルオロリン酸ナトリウム 0.73
フッ素イオン量 0.096
無水ケイ酸(研磨剤) 12
ソルビット液(70%) 40
サッカリンナトリウム 0.2
増粘性シリカ 6
酸化チタン 0.5
プロピレングリコール 3
キサンタンガム 0.7
ポリアクリル酸ナトリウム 0.4
クエン酸 0.1
水酸化ナトリウム 0.1
ラウリル硫酸ナトリウム 1.5
香料 0.8
精製水 バランス
合計 100.0%
((A)+(B))/(C)=4.2 [Prescription Example 1] Toothpaste (A) Hinokitiol 0.1%
(B) L-ascorbyl magnesium phosphate 0.3
(C) Sodium monofluorophosphate 0.73
Fluorine ion content 0.096
Silicic anhydride (abrasive) 12
Sorbit liquid (70%) 40
Saccharin sodium 0.2
Thickening silica 6
Titanium oxide 0.5
Propylene glycol 3
Xanthan gum 0.7
Sodium polyacrylate 0.4
Citric acid 0.1
Sodium hydroxide 0.1
Sodium lauryl sulfate 1.5
Fragrance 0.8
Purified water balance
Total 100.0%
((A) + (B)) / (C) = 4.2
Claims (9)
- (A)ヒノキチオール、
(B)アスコルビン酸リン酸エステル又はその塩、
(C)フッ素イオン
を含有し、(C)成分の含有量が0.0001~0.27質量%であり、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000であることを特徴とする口腔用組成物。 (A) Hinokitiol,
(B) Ascorbic acid phosphate or a salt thereof,
(C) Fluorine ions are contained, the content of component (C) is 0.0001 to 0.27% by mass, and the blending ratio of components (A) and (B) to component (C) is shown (( A composition for oral cavity, wherein A) + (B)) / (C) is 0.5 to 11,000 as a mass ratio. - (B)成分が、アスコルビン酸リン酸エステルマグネシウム塩である請求項1記載の口腔用組成物。 The composition for oral cavity according to claim 1, wherein the component (B) is an ascorbic acid phosphate magnesium salt.
- (C)フッ素イオンの供給源が、フッ化ナトリウム、モノフルオロリン酸ナトリウム及びフッ化スズから選ばれる1種以上のフッ素含有化合物である請求項1又は2記載の口腔用組成物。 (C) The composition for oral cavity according to claim 1 or 2, wherein the source of fluorine ions is one or more fluorine-containing compounds selected from sodium fluoride, sodium monofluorophosphate and tin fluoride.
- (A)成分の配合量が組成物中0.005~0.5質量%、(B)成分の配合量が組成物中0.1~5質量%である請求項1~3のいずれか1項記載の口腔用組成物。 The blending amount of component (A) is 0.005 to 0.5 mass% in the composition, and the blending amount of component (B) is 0.1 to 5 mass% in the composition. The composition for oral cavity according to item.
- 更に、シリカ系研磨剤を2~40質量%含有する請求項1~4のいずれか1項記載の口腔用組成物。 The oral composition according to any one of claims 1 to 4, further comprising 2 to 40% by mass of a silica-based abrasive.
- シリカ系研磨剤以外の研磨剤の含有量が0~10質量%である請求項5記載の口腔用組成物。 The composition for oral cavity according to claim 5, wherein the content of the abrasive other than the silica-based abrasive is 0 to 10% by mass.
- 歯磨剤組成物である請求項1~6のいずれか1項記載の口腔用組成物。 The oral composition according to any one of claims 1 to 6, which is a dentifrice composition.
- (A)ヒノキチオール及び(B)アスコルビン酸リン酸エステル又はその塩を配合した口腔用組成物に、(C)フッ素イオンを0.0001~0.27質量%、かつ(C)成分に対する(A)及び(B)成分の配合割合を示す((A)+(B))/(C)が質量比として0.5~11,000の範囲内で配合することを特徴とする、前記口腔用組成物における(A)及び(B)成分による製剤変色及び液分離の抑制方法。 (A) 0.001 to 0.27% by mass of fluorine ions in (C) component and (A) the component for oral cavity containing hinokitiol and (B) ascorbic acid phosphate or salt thereof And (B) component ratio ((A) + (B)) / (C) is blended within the range of 0.5 to 11,000 as a mass ratio. A method for suppressing discoloration and liquid separation by the components (A) and (B) in the product.
- 口腔用組成物が、更に(D)シリカ系研磨剤を2~40質量%配合した口腔用組成物である請求項8記載の製剤変色及び液分離の抑制方法。 The method for suppressing discoloration and liquid separation according to claim 8, wherein the composition for oral cavity further comprises (D) 2-40% by mass of a silica-based abrasive.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016197910A JP2018058795A (en) | 2016-10-06 | 2016-10-06 | Composition for oral cavity and method for suppressing color change of preparation and liquid separation |
JP2016-197910 | 2016-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018066341A1 true WO2018066341A1 (en) | 2018-04-12 |
Family
ID=61831433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/033453 WO2018066341A1 (en) | 2016-10-06 | 2017-09-15 | Oral composition and method for suppressing discoloration of formulation and liquid separation thereof |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2018058795A (en) |
WO (1) | WO2018066341A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021033662A1 (en) * | 2019-08-19 | 2021-02-25 | 小林製薬株式会社 | Gingival tissue destruction inhibiting agent |
WO2021033661A1 (en) * | 2019-08-19 | 2021-02-25 | 小林製薬株式会社 | Gingival epithelial cell activator |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6882222B2 (en) | 2018-03-26 | 2021-06-02 | Eneos株式会社 | Failure diagnosis method of the pressure gauge of the hydrogen filling system and calibration method of the pressure gauge of the hydrogen filling system |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5399339A (en) * | 1977-02-09 | 1978-08-30 | Sunstar Inc | Tooth paste composition |
JPH02292210A (en) * | 1989-05-08 | 1990-12-03 | Lion Corp | Oral cavity composition |
JPH1112142A (en) * | 1997-06-19 | 1999-01-19 | Lion Corp | Oral composition |
JPH11286422A (en) * | 1998-03-31 | 1999-10-19 | Lion Corp | Composition for oral cavity application |
JP2002114656A (en) * | 2000-10-05 | 2002-04-16 | Nippon Zettoc Co Ltd | Base material for composition for oral cavity and composition for oral cavity |
JP2009263375A (en) * | 2002-07-29 | 2009-11-12 | Warner-Lambert Co Llc | Oral care composition comprising tropolone compound and essential oil |
JP2015127305A (en) * | 2013-12-27 | 2015-07-09 | 小林製薬株式会社 | Oral composition |
JP2017007991A (en) * | 2015-06-25 | 2017-01-12 | ライオン株式会社 | Composition for oral cavity and method for improving bactericidal activity of hinokitiol in the composition |
-
2016
- 2016-10-06 JP JP2016197910A patent/JP2018058795A/en active Pending
-
2017
- 2017-09-15 WO PCT/JP2017/033453 patent/WO2018066341A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5399339A (en) * | 1977-02-09 | 1978-08-30 | Sunstar Inc | Tooth paste composition |
JPH02292210A (en) * | 1989-05-08 | 1990-12-03 | Lion Corp | Oral cavity composition |
JPH1112142A (en) * | 1997-06-19 | 1999-01-19 | Lion Corp | Oral composition |
JPH11286422A (en) * | 1998-03-31 | 1999-10-19 | Lion Corp | Composition for oral cavity application |
JP2002114656A (en) * | 2000-10-05 | 2002-04-16 | Nippon Zettoc Co Ltd | Base material for composition for oral cavity and composition for oral cavity |
JP2009263375A (en) * | 2002-07-29 | 2009-11-12 | Warner-Lambert Co Llc | Oral care composition comprising tropolone compound and essential oil |
JP2015127305A (en) * | 2013-12-27 | 2015-07-09 | 小林製薬株式会社 | Oral composition |
JP2017007991A (en) * | 2015-06-25 | 2017-01-12 | ライオン株式会社 | Composition for oral cavity and method for improving bactericidal activity of hinokitiol in the composition |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021033662A1 (en) * | 2019-08-19 | 2021-02-25 | 小林製薬株式会社 | Gingival tissue destruction inhibiting agent |
WO2021033661A1 (en) * | 2019-08-19 | 2021-02-25 | 小林製薬株式会社 | Gingival epithelial cell activator |
JP2021031406A (en) * | 2019-08-19 | 2021-03-01 | 小林製薬株式会社 | Gingival tissue destruction inhibitor |
JP2021031405A (en) * | 2019-08-19 | 2021-03-01 | 小林製薬株式会社 | Gingival epithelial cell activator |
JP7424769B2 (en) | 2019-08-19 | 2024-01-30 | 小林製薬株式会社 | Gingival epithelial cell activator |
JP7424770B2 (en) | 2019-08-19 | 2024-01-30 | 小林製薬株式会社 | Gingival tissue destruction inhibitor |
Also Published As
Publication number | Publication date |
---|---|
JP2018058795A (en) | 2018-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6201851B2 (en) | Dentifrice composition | |
WO2013094312A1 (en) | Dentrifice composition | |
WO2011055709A1 (en) | Dentifrice composition | |
WO2011055707A1 (en) | Dentifrice composition | |
JP6610561B2 (en) | Oral composition | |
WO2018066341A1 (en) | Oral composition and method for suppressing discoloration of formulation and liquid separation thereof | |
JP5493732B2 (en) | Oral composition | |
JP7447470B2 (en) | dentifrice composition | |
JP5570777B2 (en) | Oral composition | |
JP2015117215A (en) | Dentifrice composition | |
WO2017110582A1 (en) | Composition for oral cavity | |
JPH0772124B2 (en) | Oral composition | |
CN103402490A (en) | Dentifrice composition | |
JP2009137897A (en) | Dentifrice composition | |
CN111902125B (en) | Oral composition and bitterness improver of alpha-olefin sulfonate | |
JP2014214107A (en) | Dentifrice composition | |
JP7087783B2 (en) | Oral composition | |
JP6435852B2 (en) | Oral composition and method for preventing discoloration of oral composition | |
JP7342688B2 (en) | Oral composition | |
JP2018203714A (en) | Oral composition | |
WO2019216108A1 (en) | Oral composition | |
JP2007169201A (en) | Composition for oral cavity | |
JP2010037293A (en) | Dentifrice composition | |
JPH10167939A (en) | Composition for oral cavity | |
JP6617535B2 (en) | Dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17858180 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17858180 Country of ref document: EP Kind code of ref document: A1 |